Targeting eIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer is a research paper published in Journal of Clinical Investigation (2023). On theSindex it has a DataRank of 0.515. It has been cited 30 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.515
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIH
Grant: CA16303-46
CPRIT
Grant: RP220468
National Institutes of Health
Grant: 5P50CA058223-12
SPORE in Breast Cancer
National Institutes of Health
Grant: 3P30CA125123-09S3
Baylor College of Medicine Cancer Center
National Institutes of Health
Grant: 5R01CA220468-05
Organic nanoparticles for dual MRI-guided therapeutic selection and ovarian cancer drug delivery
National Institutes of Health
Grant: 5R01CA148761-03
Therapeutic Targeting of Breast Cancer Tumor Initiating Cells
National Institutes of Health
Grant: 3P50CA186784-10S1
Translational Research in Breast Cancer
National Institutes of Health
Grant: 1P50HD103555-01
Baylor College of Medicine Intellectual and Developmental Disabilities Research Center
NCI NIH HHS
Grant: R37 CA016303
NCI NIH HHS
Grant: R01 CA148761
NCI NIH HHS
Grant: P50 CA058223
NCI NIH HHS
Grant: P30 CA125123
NCRR NIH HHS
Grant: S10 RR024574
NCI NIH HHS
Grant: R01 CA016303
NICHD NIH HHS
Grant: P50 HD103555
NCI NIH HHS
Grant: P50 CA186784
Fields of Study
MeSH Terms
Keywords